Homology Medicines, Inc. (FIXX)
(Delayed Data from NSDQ)
$22.32 USD
+0.63 (2.90%)
Updated May 3, 2019 04:00 PM ET
After-Market: $22.27 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.32 USD
+0.63 (2.90%)
Updated May 3, 2019 04:00 PM ET
After-Market: $22.27 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Homology Medicines (FIXX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
by Zacks Equity Research
Homology Medicines (FIXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Generic-Drugs Stock Outlook: No Respite from Pricing Issues
by Zacks Equity Research
Generic drugmakers, in general, are having a rather poor year, primarily due to ongoing pricing pressure and rising competition.
Lilly (LLY) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Lilly (LLY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Homology Medicines Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Homology Medicines has been struggling lately, but the selling pressure may be coming to an end soon.